Delivery Order SPE2DB20D1100-SPE2DB24FA4U6
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,747.25 firm fixed-price contract is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
- This is a $33,734.79 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S. The contract has an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December 2026....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S pharmaceuticals. The $16,063.69 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations for this award. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug...
- This is a $18,193.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of May 30, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DESCOVY 200-25 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of February 16, 2024 and a potential value of $5,323.55. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is issued under an indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DESCOVY 200-25 MG TABLET UU 30S. The $2,589.45 award has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET in the amount of $27,856.56. The order has an ultimate completion date of August 2, 2024. Amerisourcebergen is a large for-profit organization that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of...
- This is a $39,852.38 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DESCOVY 200-25 MG TABLET (a prescription medication), with a period of performance ending on March 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $12,390.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication, with an ultimate completion date of July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of DESCOVY 200-25 MG TABLET in quantities of 30 per shipment, with a potential value of $3,090.39 and a completion date of January 18, 2024. Amerisourcebergen Drug Corp, operating through its Corporate Office division, is a prime contractor providing pharmaceutical products and medical supplies to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA4U6Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The order is for the pharmaceutical product DESCOVY 200-25 MG TABLET, with a potential value of $4,902.79 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a for-profit organization that frequently receives federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This order does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications, as well as a single award indefinite delivery contract with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 2/29/24 |